SI9620030A - 17-difluormetilen-estratrieni - Google Patents

17-difluormetilen-estratrieni Download PDF

Info

Publication number
SI9620030A
SI9620030A SI9620030A SI9620030A SI9620030A SI 9620030 A SI9620030 A SI 9620030A SI 9620030 A SI9620030 A SI 9620030A SI 9620030 A SI9620030 A SI 9620030A SI 9620030 A SI9620030 A SI 9620030A
Authority
SI
Slovenia
Prior art keywords
difluoromethylene
ester
hydrogen atom
group
methyl
Prior art date
Application number
SI9620030A
Other languages
English (en)
Slovenian (sl)
Inventor
Rolf Bohlmann
Gabor Rubanyl
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of SI9620030A publication Critical patent/SI9620030A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Ceramic Products (AREA)
  • Vehicle Body Suspensions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Exhaust-Gas Circulating Devices (AREA)
  • Electrical Control Of Air Or Fuel Supplied To Internal-Combustion Engine (AREA)
SI9620030A 1995-03-13 1996-03-13 17-difluormetilen-estratrieni SI9620030A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19509729A DE19509729A1 (de) 1995-03-13 1995-03-13 17-Difluormethylen-Estratriene
PCT/EP1996/001069 WO1996028462A1 (de) 1995-03-13 1996-03-13 17-difluormethylen-estratriene

Publications (1)

Publication Number Publication Date
SI9620030A true SI9620030A (sl) 1998-02-28

Family

ID=7756963

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9620030A SI9620030A (sl) 1995-03-13 1996-03-13 17-difluormetilen-estratrieni

Country Status (21)

Country Link
US (2) US6018062A (cs)
EP (1) EP0815120B1 (cs)
JP (1) JPH11501644A (cs)
KR (1) KR19980703002A (cs)
AT (1) ATE199159T1 (cs)
AU (1) AU693335B2 (cs)
BR (1) BR9612787A (cs)
CA (1) CA2215201A1 (cs)
CZ (1) CZ281097A3 (cs)
DE (2) DE19509729A1 (cs)
HU (1) HUP9801846A3 (cs)
IL (1) IL117497A (cs)
IS (1) IS4556A (cs)
NO (1) NO308306B1 (cs)
PL (1) PL322199A1 (cs)
RU (1) RU2155770C2 (cs)
SI (1) SI9620030A (cs)
SK (1) SK121697A3 (cs)
TR (1) TR199700950T1 (cs)
WO (1) WO1996028462A1 (cs)
ZA (1) ZA962037B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
AU2003264866A1 (en) * 2003-08-11 2005-02-25 Industria Chimica Reggiana I.C.R. S.P.A. Chemical composition and method of polymerisation thereof for use on vehicle bodywork repair
WO2006002907A1 (en) * 2004-06-29 2006-01-12 Jadolabs Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5783571A (en) * 1991-01-07 1998-07-21 Pherin Corporation Method of altering hypothalamic function by nasal administration of estrene steroids
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)

Also Published As

Publication number Publication date
PL322199A1 (en) 1998-01-19
IS4556A (is) 1997-09-08
NO308306B1 (no) 2000-08-28
CA2215201A1 (en) 1996-09-19
TR199700950T1 (xx) 1998-02-21
IL117497A (en) 1999-12-22
US6018062A (en) 2000-01-25
DE59606435D1 (de) 2001-03-22
WO1996028462A1 (de) 1996-09-19
KR19980703002A (ko) 1998-09-05
RU2155770C2 (ru) 2000-09-10
SK121697A3 (en) 1998-02-04
AU693335B2 (en) 1998-06-25
MX9707006A (es) 1997-11-29
BR9612787A (pt) 1999-11-23
EP0815120B1 (de) 2001-02-14
JPH11501644A (ja) 1999-02-09
HUP9801846A2 (hu) 1998-12-28
HUP9801846A3 (en) 1999-03-01
CZ281097A3 (cs) 1998-02-18
ZA962037B (en) 1996-09-25
NO974206L (no) 1997-11-13
EP0815120A1 (de) 1998-01-07
IL117497A0 (en) 1996-07-23
NO974206D0 (no) 1997-09-12
US6136800A (en) 2000-10-24
ATE199159T1 (de) 2001-02-15
AU5107896A (en) 1996-10-02
DE19509729A1 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
CA1266466A (fr) Procede de preparation de steroides substitues en position 10
KR100333151B1 (ko) 단량체성담즙산유도체
US4235893A (en) Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
US5512558A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
JP3887020B2 (ja) アズレニルニトロンスピントラッピング剤、ならびにその製造方法および使用方法
EP0728140B1 (de) Neue steroide mit radikophilen substituenten, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4202891A (en) 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
CA1306248C (en) Androstane-17-carboxylic acid esters process for their preparation and medecine containing them
WO1996000236A1 (en) Triterpene derivative and medicinal composition
SI9620030A (sl) 17-difluormetilen-estratrieni
PL138796B1 (en) Process for preparing novel 6 alpha-methylcorticoids
FI92706C (fi) Menetelmä 19-hydroksylaasi-inhibiittoreina käyttökelpoisten 19-substituoitujen progesteronijohdannaisten valmistamiseksi
Sandor et al. THE METABOLISM OF ALDOSTERONE: II. Studies» in vitro «and» in vivo «in man
NO168892B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropyloxy)androst-5-en-3beta-ol-derivater
CA1146533A (en) 11-methylene steroids, process for their manufacture and pharmaceutical preparations containing them
MXPA97007006A (en) 17-difluorometil stratrenes
WO1985005623A1 (fr) Agent de traitement de l'arteriosclerose
US6413951B2 (en) 20-fluoro-17(20)-vinyl steroids
HU180931B (en) Process for preparing 2-substituted 19-nor-steroids
Rao et al. Isolation and identification of androstanediol glucuronide from human plasma
JP3034095B2 (ja) カテコールエストロゲン配糖体及びその用途
SK11897A3 (en) 17alpha-dammara compounds, preparation method thereof, pharmaceutical compositions containing them and their use
JP3034093B2 (ja) カテコールエストロゲン配糖体及びその用途
US3634467A (en) 1alpha 2alpha-methylene-6-trifluoromethyl steroids
DE3514272A1 (de) Dermatica